Pharmacor
Pharmacor Pty Ltd is an Australian pharmaceutical company, founded in 2007 and wholly-owned by Alkem Laboratories (NSE: ALKEM), that supplies generic prescription and OTC medications across 15 therapeutic categories to community pharmacies and hospitals nationwide, distributed through API, CH2, Sigma, and Symbion wholesalers.
- Company typePrivate
- Founded2007
- HeadquartersChatswood, Australia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pharmacor does
Pharmacor Pty Ltd is an Australian pharmaceutical company founded in 2007 and headquartered in Chatswood, NSW, that supplies generic prescription and over-the-counter medications to community pharmacies and hospitals across Australia. The company operates as the wholly-owned Australian commercial subsidiary of Alkem Laboratories, an Indian pharmaceutical conglomerate publicly listed on the NSE (NSE: ALKEM) with operations spanning more than 50 countries, 21 manufacturing facilities, and 6 R&D centres employing over 500 researchers. Pharmacor's portfolio spans 15 therapeutic categories including cardiovascular, central nervous system, endocrine, anti-infectives, gastrointestinal, immunomodulators and antineoplastics, genitourinary, and dermatological products, with close to 60 products registered with the TGA for the Australian market.
The company's underlying technical capability is inherited from parent Alkem's formulation science, including expertise in fixed-dose combinations, complex generics, bioequivalence and bioavailability studies via an independent 112-bed clinical research facility, non-infringing generic formulation development under Hatch-Waxman patent challenge strategies, and novel drug delivery systems (transdermal patches, oral films, osmotic systems). Pharmacor's commercial product range includes branded prescription generics under the Pharmacor label and consumer-facing OTC products under the Trust sub-brand, the Trust for Kids pediatric line, and the Skin Basics dermatological skincare range.
Pharmacor generates revenue through the sale of generic pharmaceuticals to two primary customer segments: Australian community pharmacies (mid-market) and Australian hospital systems (enterprise), distributed via a hybrid model of direct sales and four major Australian pharmaceutical wholesalers (API, CH2, Sigma, Symbion). The company is certified as a Family Friendly Workplace and parent Alkem holds ISO 14001:2015 environmental management certification. No public revenue or headcount trajectory figures are disclosed, and Pharmacor has no independent funding rounds as a strategic subsidiary of Alkem Laboratories.
Pharmacor firmographics
Firmographics- Name
- Pharmacor
- Legal name
- Pharmacor Pty Ltd
- Website
- https://pharmacor.com.au
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Pharmacor Pty Ltd is an Australian pharmaceutical company, founded in 2007 and wholly-owned by Alkem Laboratories (NSE: ALKEM), that supplies generic prescription and OTC medications across 15 therapeutic categories to community pharmacies and hospitals nationwide, distributed through API, CH2, Sigma, and Symbion wholesalers.
- Ownership category
- akta.pro rank
Pharmacor industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ)
Keywords
Where Pharmacor is headquartered
LocationHeadquarters
- HQ city
- Chatswood
- HQ country
- Australia
- HQ region
- Oceania
Offices7 records
Markets served
Pharmacor business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D
Revenue model
- Prescription Generic Medications: Sale of prescription generic pharmaceutical products to pharmacies and hospitals. Includes a wide range of therapeutic categories including cardiovascular, central nervous system, immunomodulators, anti-infectives, and more.
- Over-the-Counter (OTC) Products: Sale of OTC generic medications including pain management, cold & flu, hayfever & allergies, gastrointestinal, dermatological, and general health products.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Pharmacor product offering
Product offeringCore offering
Pharmacor is an Australian pharmaceutical company that supplies generic prescription (Rx) and over-the-counter (OTC) medications to pharmacies and hospitals across Australia. The company operates as a subsidiary of Alkem Laboratories, distributing its portfolio of generic medicines through direct sales and established pharmaceutical wholesalers.
Product overview
Pharmacor is an Australian pharmaceutical company that supplies generic prescription (Rx) and over-the-counter (OTC) medications across 15 therapeutic categories. The product portfolio consists of two main sub-brands: Pharmacor-branded prescription products covering Cardiovascular & Blood, Central Nervous System, Gastrointestinal, Endocrine, Immunomodulators & Antineoplastics, Anti-Infectives, Genitourinary, and Dermatological conditions; and the Trust OTC brand offering consumer health products including cold & flu, hayfever & allergies, pain management, digestive health, feminine health, and general wellness items. Additional sub-brands include Skin Basics (dermatological skincare products), Trust for Kids (pediatric medications), and standalone products like Cal-Care, Gastrex, and Nystatin Oral Drops. The company operates through wholesale distribution channels including API, CH2, Sigma, and Symbion, and sells directly to pharmacies and hospitals throughout Australia.
Differentiator
Problem solved
Functional benefit
Brands
- Trust: Over-the-counter consumer health brand including Trust for Kids (children's medications), Trust Aspirin EC, Trust Calcium + Vitamin D, Trust Cold & Flu + Cough, Trust Cetirizine, and various other OTC products.
- Skin Basics
Products and services
- Generic Prescription (Rx) Medications A portfolio of generic prescription pharmaceutical products supplied to pharmacies and hospitals across Australia, offering affordable alternatives to branded medications.
- Over-the-Counter (OTC) Medications A range of over-the-counter pharmaceutical products sold through pharmacies in Australia for consumer self-medication needs.
Quantifiable outcome
- Over 140 ANDAs filed with USA FDA demonstrating regulatory success and market reach
- +2 more outcomes
Companies that use Pharmacor
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles1 record
Pharmacor technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Pharmacor partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Alkem LaboratoriescorePharmacor is a subsidiary of Alkem Laboratories, benefiting from their decades of experience, global reach in over 50 countries, 21 facilities, and 6 research and development centres. Alkem develops novel generic formulations for Pharmacor, allowing non-infringing generics to be provided to Australian patients. Their TGA & FDA approved manufacturing facilities support Pharmacor's quality and compliance requirements.
- API HealthcarecoreMajor Australian pharmaceutical wholesaler distributing Pharmacor products to pharmacies and healthcare facilities nationwide
- CH2coreMajor Australian pharmaceutical wholesaler distributing Pharmacor products to pharmacies and healthcare facilities nationwide
- Sigma HealthcarecoreMajor Australian pharmaceutical wholesaler distributing Pharmacor products to pharmacies and healthcare facilities nationwide through SigmaConnect platform
- SymbioncoreMajor Australian pharmaceutical wholesaler distributing Pharmacor products to pharmacies and healthcare facilities nationwide
- Enzene Biosciences LimitedcorePart of Alkem Laboratories group, Enzene Biosciences operates R&D facilities in Pune, India supporting development of biosimilars and biologic products. Located at MIDC, Bhosari and Pimpri-Chinchwad, Pune.
- Norac PharmaminorAlkem Laboratories subsidiary operating R&D facility in Azusa, CA, USA supporting Pharmacor's product development capabilities
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Pharmacor competitors and assessment
Company assessmentDirect peers
- Arrotex Pharmaceuticals: Arrotex is Australia's largest generic pharmaceutical supplier, formed from the merger of several local players including Apotex Australia. It supplies prescription and OTC generics to community pharmacies and hospitals nationwide — directly comparable to Pharmacor in product mix, customer base, and Australian distribution model.
- Apotex Australia: Apotex is a Canadian-headquartered generic pharmaceutical company with significant Australian operations and one of the most extensive generic portfolios in the country. It directly competes with Pharmacor on prescription generics across multiple therapeutic categories.
- Cipla Australia: Cipla is an Indian-headquartered generic pharmaceutical major with an Australian subsidiary supplying prescription and OTC generics. Like Pharmacor, it leverages Indian parent manufacturing and R&D for the Australian market, making it a structurally similar comparator.
- AFT Pharmaceuticals: AFT Pharmaceuticals is a New Zealand/Australia-focused specialty pharma company offering prescription and OTC products in similar therapeutic categories. It is comparable to Pharmacor in regional focus and product mix, including consumer health brands.
- Accord Healthcare: Accord Healthcare is the Australian arm of Intas Pharmaceuticals, supplying prescription generic medicines across oncology, CNS, cardiovascular, and other categories. It is a direct Indian-origin competitor in the Australian generic market with overlapping therapeutic coverage.
Broad incumbents
- Sandoz (Novartis division): Sandoz is the global generic and biosimilar arm of Novartis and a major supplier of generic prescription medicines in Australia. It competes directly with Pharmacor across cardiovascular, CNS, and anti-infective categories, but at much greater global scale and with broader biosimilar exposure.
- Viatris (Alphapharm): Viatris (formerly Mylan, which merged with Upjohn/Pfizer) operates the historic Alphapharm business in Australia — one of the country's largest generic pharmaceutical companies. It offers a comparable portfolio of prescription generics distributed through the same major wholesalers used by Pharmacor.
Emerging players
- Lupin Australia: Lupin is an Indian generic pharmaceutical major with an Australian presence supplying prescription generics. It is comparable to Pharmacor as another Indian parent-backed generic supplier competing in the Australian market, though with a more focused specialty portfolio.
Others
- Sigma Healthcare: Sigma Healthcare is one of Australia's largest pharmaceutical wholesalers and retailers (Amcal, Guardian, Chemist King). It is both a distribution partner and adjacent competitor with its own private-label and generic participation, making it a relevant channel and ecosystem peer.
Regional players
- Mayne Pharma: Mayne Pharma is an Australia-founded specialty pharmaceutical company with a focus on generic and specialty products, particularly in women's health and dermatology. It is comparable as an Australian-headquartered pharma with a mix of generic and branded specialty products.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Pharmacor social profiles
Digital presencePharmacor compliance and trust
Trust signalCompliance3 records
Pharmacor financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharmacor leadership team
Management profileNumber of profiles
Pharmacor funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharmacor M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharmacor
What does Pharmacor do?
Pharmacor is an Australian pharmaceutical company that supplies generic prescription (Rx) and over-the-counter (OTC) medications to pharmacies and hospitals across Australia. The company operates as a subsidiary of Alkem Laboratories, distributing its portfolio of generic medicines through direct sales and established pharmaceutical wholesalers.
Is Pharmacor a public or private company?
Pharmacor is a private company. It is classified as corporate owned and is currently operating.
When was Pharmacor founded?
Pharmacor was founded in 2007. It employs 11 to 50 people.
Where is Pharmacor based?
Pharmacor is headquartered in Chatswood, Australia, in the Oceania region.
How does Pharmacor make money?
Two revenue lines are on record. Prescription Generic Medications are the primary driver. The others are over-the-Counter (OTC) Products.
Who are Pharmacor's main competitors?
Direct peers on record are Arrotex Pharmaceuticals, Apotex Australia, Cipla Australia, AFT Pharmaceuticals and Accord Healthcare. Broad incumbents are Sandoz (Novartis division) and Viatris (Alphapharm). Lupin Australia is listed as an emerging player. Sigma Healthcare is listed as an others. Mayne Pharma is listed as a regional player.
Does Pharmacor have an API?
No public API is recorded for Pharmacor.
What industry is Pharmacor in?
Pharmacor's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAJ, Generic ANDA/Regulatory Affairs & Submissions. Its NAICS code is 325412 and its SIC code is 2834.